Irritable bowel syndrome (IBS)— characterized by abdominal pain, bloating, and altered bowel habit-;may last 4 or more years following a bout of gastroenteritis in around
Listen to the article 11 min This audio is auto-generated. Please let us know if you have feedback. Laboratories are just beginning to assess the
Treatment with the antibody drug-conjugate ifinatamab deruxtecan (I-DXd) showed promising activity in pretreated patients with extensive-stage small cell lung cancer (SCLC), particularly those treated at